Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster.

Wagenhäuser, Isabell; Reusch, Julia; Gabel, Alexander; Krone, Lukas B; Kurzai, Oliver; Petri, Nils; Krone, Manuel (2023). Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster. Clinical microbiology and infection, 29(4), pp. 554-556. Elsevier 10.1016/j.cmi.2023.01.008

[img]
Preview
Text
1-s2.0-S1198743X23000307-main.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (505kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy

UniBE Contributor:

Krone, Lukas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1469-0691

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

25 Jan 2023 14:49

Last Modified:

18 Jan 2024 00:25

Publisher DOI:

10.1016/j.cmi.2023.01.008

PubMed ID:

36657489

BORIS DOI:

10.48350/177701

URI:

https://boris.unibe.ch/id/eprint/177701

Actions (login required)

Edit item Edit item
Provide Feedback